Aldeyra Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.01.18	WONDER EYE Allows for Efficient, Sanitary Eye Cleaning (MIS-300) (PR Newswire)
29.11.17	Aldeyra Therapeutics Presents Noninfectious Anterior Uveitis Phase 2 Clinical Trial Data to the American Uveitis Society Held at the American Academy of Ophthalmology 2017 Annual Meeting (PR Newswire)
09.11.17	Aldeyra Therapeutics Announces Third Quarter 2017 Financial Results (PR Newswire)
07.11.17	Aldeyra Therapeutics to Present at the Stifel 2017 Healthcare Conference (PR Newswire)
02.11.17	Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Third Quarter 2017 Financial Results (PR Newswire)
25.10.17	Aldeyra Therapeutics Announces Presentation of Results on the Efficacy of ADX-102 in Noninfectious Anterior Uveitis at the American Uveitis Society Held at the American Academy of Ophthalmology... (PR Newswire)
24.10.17	Aldeyra Therapeutics Presents Evidence for Aldehyde Sequestration as a Potential Therapeutic Approach in Succinic Semialdehyde Dehydrogenase Deficiency at the American Society of Human Genetics... (PR Newswire)
10.10.17	Aldeyra Therapeutics Announces New Data at 2017 Research & Development Day (PR Newswire)
05.10.17	Aldeyra Therapeutics Announces Presentation of Novel Data on the Efficacy of ADX-102 in a Model of Succinic Semialdehyde Dehydrogenase Activity at the 2017 American Society of Human Genetics Annual... (PR Newswire)
27.09.17	/C O R R E C T I O N -- Aldeyra Therapeutics, Inc./ (PR Newswire)
27.09.17	Aldeyra Therapeutics Announces 2017 Research and Development Day (PR Newswire)
20.09.17	Aldeyra Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
19.09.17	Aldeyra Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock (PR Newswire)
18.09.17	Keep An Eye On These Biotech Stocks This Month, If Invested (RTTNews)
15.09.17	FinancialInsiders.com Earnings Recap Week Ending September 15th, 2017 (PR Newswire)
15.09.17	HALO Just Got Brighter - What Other Pharma Stocks Made News This Week? (RTTNews)
13.09.17	Biotechs Ramp up Clinical Trial Programs as FDA Looks at More Efficient Drug Development Programs (PR Newswire)
13.09.17	Biotechs Ramp up Clinical Trial Programs as FDA Looks at More Efficient Drug Development Programs (PR Newswire)
13.09.17	Astellas, KMPH, SRNE To Face FDA, ALXN Trims Workforce, ALDX Soars On Trial Data (RTTNews)
12.09.17	Aldeyra Therapeutics Announces Positive Results from Dry Eye Disease Phase 2a Clinical Trial (PR Newswire)
12.09.17	Keep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted (RTTNews)
11.09.17	Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Results from Dry Eye Disease Phase 2a Clinical Trial (PR Newswire)
08.08.17	Aldeyra Therapeutics Announces Second Quarter 2017 Financial Results (PR Newswire)
03.08.17	Aldeyra Therapeutics to Present at the 37th Annual Canaccord Genuity Growth Conference (PR Newswire)
01.08.17	Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Second Quarter 2017 Financial Results (PR Newswire)
19.07.17	FDA Nod For GILD, It's Take 2 For AEZS' Macrilen, VRTX Soars On CF Drug Trials (RTTNews)
18.07.17	Aldeyra Therapeutics Announces Last Patient Dosed in Dry Eye Disease Phase 2a Clinical Trial (PR Newswire)
19.06.17	Aldeyra Therapeutics to Present Novel Data on the Anti-Inflammatory Mechanism and Activity of ADX-102 at the World Congress on Inflammation 2017 Annual Meeting (PR Newswire)
15.06.17	ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar (RTTNews)
14.06.17	Aldeyra Therapeutics Announces Results from Allergic Conjunctivitis Phase 2b Clinical Trial and Plans for Phase 3 Clinical Testing (PR Newswire)
14.06.17	Keep An Eye On ALDX Today (RTTNews)
13.06.17	Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Results from Allergic Conjunctivitis Phase 2b Clinical Trial (PR Newswire)
06.06.17	Aldeyra Therapeutics Announces First Patient Enrolled in Dry Eye Disease Phase 2a Clinical Trial (PR Newswire)
21.04.17	Gainers & Losers Of Apr.20: IMNP, AKTX, IMGN, ALDX, KMPH... (RTTNews)
08.02.17	FLXN Gets FDA Date, KTOV In Crosshairs, It's A Thumbs Up For AMGN (RTTNews)
26.01.17	ELGX Abuzz, ESPR Ahead Of Schedule, Tough Times For VIVO (RTTNews)
10.08.16	Eagle Gets Its Wings, Busy Year Ahead For CPRX, VYGR On Track (RTTNews)
08.06.16	ALDX Expects Data In Q3, CATB Tumbles On Study Data, Teva Gets FDA Panel Nod (RTTNews)
27.05.16	ALDX Prices Offering At $5.00/Share (RTTNews)
10.05.16	NLNK Fails To Impress, TBPH Gets FDA Nod, It's A Make Or Break Month For TNXP (RTTNews)
17.12.15	FDA Lifts Clinical Hold On ADXS, CPRX Awaits Next Catalyst, All Is Well For ACST (RTTNews)
12.08.15	INGN Lifts Outlook, BCLI Awaits DSMB Review, TRVN To Report Data Next Month (RTTNews)
17.04.15	SSH Shines, First Generic MS Drug Approved, MNOV On Fast Track, ALDX On Watch (RTTNews)
25.03.15	CLRB Sets Agenda, FDA Authorizes Xpert Ebola, Lpath Loses Track, OCAT Eyes PSCs (RTTNews)
18.03.15	Deal Ignites Ignyta, ESPR Surges On Study Results, MCUR Ahead Of Timeline (RTTNews)
19.06.14	Aldeyra Therapeutics Appoints Stephen Tulipano As CFO - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Roche Hldg G	307.30	3.64 %	K V
CieFinRichemont	162.10	2.37 %	K V
Givaudan	4’067.00	2.11 %	K V
Swiss Re	147.15	2.08 %	K V
UBS Group	28.08	1.52 %	K V
Geberit	577.00	0.17 %	K V
Sonova Hldg	273.90	-0.07 %	K V
Swisscom	530.00	-0.19 %	K V
Kuehne+Nagel Int	208.20	-1.23 %	K V
Logitech Intl	79.72	-2.18 %	K V

Nachrichten zu Aldeyra Therapeutics

Aktien Top/Flop

Meistgelesene Nachrichten